Dual roles of sulforaphane in cancer treatment.

Anti-cancer Agents in Medicinal Chemistry
Tongzhen XuGuotao Yang

Abstract

Sulforaphane (SFN), one of naturally occurring isothiocyanates (ITCs), has huge cancer chemopreventive potential. It modulates cell death, cell cycle, angiogenesis, susceptibility to carcinogens, invasion and metastasis and possesses antioxidant activities. It functions as an inhibitor of phase I enzymes and also as an inducer of phase II detoxification enzymes through different ways. NF-E2- related factor-2(Nrf-2), as well as mitogen-activated protein kinase (MAPK), is regulated by SFN. Intriguingly, strong evidence has showed the dark side of Nrf-2: stable upregulation of Nrf-2-mediated survival pathway would protect cancer cells from a subset of chemotherapeutic agents tested. This suggested that overexpression of Nrf-2 resulted in enhanced resistance of cancer cells to chemotherapeutic agents. Hence, future studies will focus on clarifying the exact time and dose of SFN to modulate the Nrf-2 signal pathway during chemotherapy and the efficacy of coadministration of Nrf-2 modulators during chemotherapy in order to make full use of the beneficial effect of this agent while eliminating the potential side effects.

Citations

Sep 18, 2012·Carcinogenesis·Andrea L BenedictAlbena T Dinkova-Kostova
Nov 25, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Małgorzata MilczarekKatarzyna Wiktorska
Jul 25, 2017·Journal of Cell Communication and Signaling·Reza Bayat MokhtariHerman Yeger
Jan 19, 2021·Journal of Oral and Maxillofacial Pathology : JOMFP·D B NandiniPraveen B Reddy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.